GENE ONLINE|News &
Opinion
Blog

Merck
Pearl Bio Enters $1 Billion Partnership Agreement with MSD for Biologic Therapies
2024-03-13
Pharmaceutical Giants Expand Research and Manufacturing Capabilities, Fueling 2024 Innovation and Growth
2024-03-01
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
GeneOnline’s Weekly News Highlights: Oct 16-Oct 20
2023-10-24
GeneOnline’s Weekly News Highlights: July 24-28
2023-08-01
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Moderna’s Cancer Vaccine to Enter Phase 3 Trials This Year
2023-04-17
Merck, Eisai’s Keytruda-Lenvima Combo Fails in Melanoma and Colorectal Cancer Trials
2023-04-10
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Merck Strikes $50 Million Deal with ModeX For Rights to EBV Vaccine
2023-03-08
Merck’s Keytruda Falls Short In Two Trials
2023-03-01
Merck Expands Hematology Portfolio With $1.35 Billion Imago Buy
2022-11-22
Merck’s Streptococcus pneumoniae Expansion Finally Receives European Commission Approval
2022-10-24
Ginkgo Bioworks and Merck’s Collaboration Worth Up to $144 million
2022-10-13
1 2 3 7
LATEST
New Regulatory Measures in China A First in the Fight Against Sedentary Behavior in Children
2024-05-24
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024
2024-05-23
AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore
2024-05-23
Hims & Hers Health Inc. Tipping the Scales of the Weight Loss Market — and Wall Street is Loving it!
2024-05-22
GV Announces Cooperation with CICC
2024-05-22
Eli Lilly and Aktis Oncology Partner to Advance Novel Radiopharmaceuticals
2024-05-22
Preventive Medicine for Neurodegeneration on the Rise: New Breakthrough in Routine Blood Testing for Alzheimer’s Disease
2024-05-20
EVENT
Scroll to Top